Blog

  • RedChip Companies Announces Sponsorship of The PIPEs Conference 2025

    RedChip Companies Announces Sponsorship of The PIPEs Conference 2025

    ORLANDO, FL / ACCESS Newswire / November 12, 2025 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its sponsorship of The PIPEs Conference 2025, hosted by DealFlow Events and taking place November 12-13, 2025, at the Hard Rock Hotel & Casino in Hollywood, Florida.

    “The PIPEs Conference has long been recognized as the definitive forum for professionals involved in private investments in public equity,” said Dave Gentry, CEO of RedChip Companies. “We’re proud to support DealFlow’s efforts in bringing back this iconic event. For more than 30 years, RedChip has helped emerging growth companies expand visibility, build investor confidence, and improve access to the capital they need to grow. This conference offers the perfect environment to engage with dealmakers and executives shaping the next generation of public market financing.”

    Now in its 20th year, The PIPEs Conference-relaunched in 2024 to overwhelming positive feedback-serves as the industry’s leading platform for discussions on regulatory developments, market trends, and transaction structures in the PIPEs space. The 2025 event will deliver unmatched networking opportunities and thought leadership, drawing institutional investors, fund managers, attorneys, and corporate executives active in the private placement market.

    As a sponsor, RedChip will spotlight its comprehensive investor relations and financial media platform, which has helped more than a thousand emerging growth companies achieve greater visibility, liquidity, and market credibility. By combining daily outreach with unmatched multimedia reach, RedChip continues to set the standard for driving tangible outcomes in the microcap and small-cap markets.

    RedChip looks forward to connecting with investors, issuers, and capital markets professionals at the conference.

    About RedChip Companies

    RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. Founded in 1992 as a small-cap research firm, RedChip gained early recognition for initiating coverage on emerging blue chip companies such as Apple, Starbucks, Daktronics, Winnebago, and Nike. Over the past 33 years, RedChip has evolved into a full-service investor relations and media firm, delivering concrete, measurable results for its clients, which have included U.S. Steel, Perfumania, and Celsius Holdings, among others. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

    To learn more about RedChip’s products and services, please visit: https://www.redchip.com/corporate/investor_relations

    “Discovering Tomorrow’s Blue Chips Today”™

    Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

    Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

    Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

    Follow RedChip on Twitter: https://twitter.com/RedChip

    Follow RedChip on YouTube: https://www.youtube.com/@redchip

    Follow RedChip on Rumble: https://rumble.com/c/c-3068340

    Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

    Contact:

    Dave Gentry
    RedChip Companies Inc.
    1-800-REDCHIP (733-2447)
    1-407-644-4256
    info@redchip.com

    SOURCE: RedChip Companies, Inc.

    View the original press release on ACCESS Newswire

  • American Critical Minerals Applauds the Newly Updated 2025 U.S. Geological Survey List of Critical Minerals Now Including Both Potash and Lithium

    American Critical Minerals Applauds the Newly Updated 2025 U.S. Geological Survey List of Critical Minerals Now Including Both Potash and Lithium

    VANCOUVER, BC / ACCESS Newswire / November 12, 2025 / American Critical Minerals Corp. (“American Critical Minerals” or the “Company“) (CSE:KCLI)(OTCQB:APCOF)(FRANKFURT:2P30) is pleased to announce that the USGS has recently updated the Secretary of the Interior, acting through the director of the U.S. Geological Survey (“USGS”) and has now finalized the 2025 list of critical minerals to include both Potash and Lithium. The updated list emphasizes “Critical minerals are essential for national security, economic stability, and supply chain resilience because they underpin key industries, drive technological innovation, and support critical infrastructure vital for a modern American economy“. Furthermore, the notice goes on to state “The Nation possesses vast mineral resources that can create jobs, fuel prosperity, and significantly reduce our reliance on foreign nations, and the United States is taking actions to facilitate domestic mineral production. The List of Critical Minerals guides strategies to secure the Nation’s mineral supply chains” (See the Federal Register as posted on 11/07/2025 and available online at https://federalregister.gov/d/2025-19813, and on https://govinfo.gov).

    Simon Clarke, President and CEO stated, “This timely announcement further underpins the importance of unlocking the potential of both Potash and Lithium within our Green River Project. Now with our recent bought deal financing closed and our technical team expanded with the appointment of Dean Pekeski, we can focus on executing our carefully designed phased drilling program(s) to confirm historical data and work towards maiden resources for both potash and lithium”.

    About American Critical Minerals’ Green River Potash and Lithium Project

    The Green River Potash and Lithium Project is situated within Utah’s highly productive Paradox Basin, located 20 miles northwest of Moab, Utah. It has significant logistical advantages including close proximity to major rail hubs, airport, roads, water, towns and labour markets. It also benefits from close proximity to the agricultural and industrial heartland of America and numerous potential end-users for its products.

    The history of oil and gas production across the Paradox Basin provides geologic data from historic wells across the Project, and the wider Basin, validating and de-risking the potential for high grade potash and large amounts of contained lithium. Wells in and around the project reported lithium up to 500 ppm, bromine up to 6,100 ppm and boron up to 1,260 ppm (Gilbride & Santos, 2012). This data is reinforced by nearby potash production and the advanced stage of neighbouring lithium projects. The Paradox Basin is believed to contain up to 56 billion tonnes of lithium brines, potentially the largest such resource in US (Source:AnsonFastmarketsPresentation- https://wcsecure.weblink.com.au/pdf/ASN/02823465.pdf ).

    The Company’s National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101“) Potash Exploration Target consists of 500 million to 950 million tonnes of sylvinite (the most important source for the production of potash in North America) grading from 12% to 18% potassium oxide based on elog (eK2O=19% to 29% potassium chloride based on elog (eKCl)). Its Exploration Targets for Lithium and Bromine are 2.1 billion cubic meters (brine volume) grading from 71.6 to 216.3 parts per million lithium; and 2.1 billion cubic meters (brine volume) grading from 3,656 to 4,741 parts per million bromine.**

    The Company holds a 100% interest in eleven State of Utah (“SITLA“) mineral and minerals salt leases covering approximately 7,050 acres, 1,094 federal lithium brine claims (BLM Placer Claims) covering 21,150 acres, and 11 federal (BLM) potash prospecting permits covering approximately 25,480 acres. Through these leases, permits and claims the Company has the ability to explore for potash, lithium and potential by-products across the entire Green River Project (approx. 32,530 acres). The Company is authorized to drill a total of 7 drill holes across the Project (pending bonding the recently approved 4 drill holes).

    Intrepid Potash, Inc. is America’s largest potash company and only U.S. domestic potash producer and currently produces potash from its nearby Moab Solution Mine, which the Company believes provides strong evidence of stratigraphic continuity within this part of the Paradox Basin (www.intrepidpotash.com). Anson Resources Ltd. has advanced lithium development projects contiguous to the northern boundary of our Green River Project and neighbouring to the south. Anson has a large initial resource, robust definitive feasibility study and has recently completed successful piloting operations through its partnership with Koch Technology Solutions, as well as an offtake agreement with LG Energy Solution. The Anson exploration targets encompass the combined Mississippian Leadville Formation and the Pennsylvanian Paradox Formation brine-bearing clastic layers, which also underlie American Critical Minerals’ entire project area (www.ansonresources.com)*.

    In 2022, the U.S. imported approx. 96.5% of its annual potash requirements with domestic producers receiving a higher sales price due to proximity to market (intrepidpotash.com/ August 15, 2024, Investor Presentation). In March 2024, the US Senate introduced a bill to include key fertilizers and potash on the US Department of Interior list of Critical Minerals which already includes lithium, and this process is well advanced with potash being added to the USGS Draft Critical Minerals List. In August 2025. Recent market estimates suggest that the global potash market is over US$50 billion annually and growing at a compound annual growth rate (“CAGR”) of close to 5%. Annual lithium demand is now estimated to be over 1 million tonnes globally and continuing to grow rapidly***.

    ****Exploration Targets are conceptual in nature and there has been insufficient exploration to define them as Mineral Resources, and, while reasonable potential may exist, it is uncertain whether further exploration will result in the determination of a Mineral Resource under NI 43-101.

    Qualified Person

    The technical content of this news release has been reviewed and approved by Dean Besserer, P.Geo., the Chief Operations Officer of the Company and a qualified person for the purposes of NI 43-101.

    On behalf of the Board of Directors

    Simon Clarke, President & CEO

    Contact: (604)-551-9665

    *American Critical Minerals’ management cautions that results or discoveries on properties in proximity to the American Critical Minerals’ properties may not necessarily be indicative of the presence of mineralization on the Company’s properties.

    **A report titled “NI 43-101 Technical Report – Green River Potash and Lithium Project, Grand County, Utah, USA”, prepared by Agapito Associates Inc., and dated October 27, 2025, quantifies the Green River Potash Project’s potash, lithium and bromine exploration potential in the form of NI 43-101 Exploration Targets. The Exploration Target estimate was prepared in accordance with NI 43-101. It should be noted that Exploration Targets are conceptual in nature and there has been insufficient exploration to define them as Mineral Resources, and, while reasonable potential may exist, it is uncertain whether further exploration will result in the determination of a Mineral Resource under NI 43-101. Details of the basis on which the Exploration Targets have been determined is included in the Report. The Exploration Target stated in the Report is not being reported as part of any Mineral Resource or Mineral Reserve. A copy of the report can be accessed on both SEDAR+ (www.sedarplus.ca) and the corporate website for the Company: www.acmineralscorp.com.

    ***United States Geological Survey, Mineral Commodity Summaries, January 2024 (https://pubs.usgs.gov/periodicals/mcs2024/mcs2024-potash.pdf).

    CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

    This news release contains forward-looking information or forward-looking statements within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussion with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often, but not always using phrases such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: use of proceeds; statements about exploration targets; goals of the Company; magnitude or quality of mineral deposits; anticipated advancement of mineral properties or programs; and future exploration prospects.

    Although the Company believes that such statements are reasonable, it can give no assurances that such expectations will prove to be correct. All such forward-looking statements are based on certain assumptions and analyses made by the Company in light of their experience and perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Forward-looking statements also involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Important factors that could cause actual results to differ from this forward-looking information include those described under the heading “Risks and Uncertainties” in the Company’s most recently filed MD&A.

    Forward-looking information contained herein are made as of the date of this news release and the Company does not intend, and expressly disclaims any obligation to, update or revise the forward-looking information contained in this news release, except as required by law. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

    Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

    SOURCE: American Critical Minerals Corp.

    View the original press release on ACCESS Newswire

  • Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line

    Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line

    New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and iron-modulating activity – key to its broader epigenetic mechanism of action.

    MIAMI, FL / ACCESS Newswire / November 12, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing therapies targeting the epigenetic roots of cancer, aging, and age-related disease, today announced new preclinical findings showing that its lead investigational compound Telomir-1 produced a strong, dose-dependent reduction of intracellular iron in human keratinocyte (HaCaT) cells – outperforming the FDA-approved gold-standard iron chelator, Deferoxamine (DFO). These results represent an important step in Telomir’s broader program to explore how metal-ion imbalance contributes to oxidative stress, aging, and disease progression.

    Live-Cell Iron Imaging Study

    The study employed FerroOrange, a fluorescent probe that selectively detects ferrous iron (Fe²⁺) inside living cells. HaCaT cells were incubated with Telomir-1 or DFO for various time points. After three, six and sixteen hours, fluorescence microscopy revealed a markedly lower intracellular iron signal in Telomir-1-treated cells, indicating strong cell penetration and iron-modulating capacity relative to DFO at the same concentrations.

    Iron, Copper, and the Biology of Aging and Disease

    Iron and copper are essential for growth and metabolism-iron supports oxygen transport and cell division, while copper contributes to connective-tissue formation, brain development, and antioxidant defense. In youth, these metals are tightly regulated; with aging, regulation weakens and reactive metals accumulate inside cells.

    Excess Fe²⁺ and Cu⁺ catalyze formation of reactive oxygen species (ROS) that damage DNA, proteins, and mitochondria. This oxidative stress and the resulting “epigenetic drift” contribute to functional decline across tissues.

    In cancer, the imbalance becomes more pronounced. Many tumors actively increase and subsequently rely on high iron levels as metabolic fuel for DNA synthesis, sustained proliferation, mitochondrial activity and rapid growth, while iron-driven changes in DNA methylation alter gene activity in ways that promote tumor survival. Restoring balanced metal levels may help reduce the cellular environment that favors genomic instability, a hallmark of aging and disease biology.

    Linking Metal Balance and Epigenetic Regulation

    Telomir’s research indicates that iron directly influences epigenetic enzymes that control gene expression.

    • Histone demethylases, including the KDM2, KDM5, and KDM6 families require Fe²⁺ as a cofactor.

    • When intracellular iron becomes excessive or oxidized, these enzymes may lose normal control, leading to aberrant DNA methylation and the silencing of protective genes such as GSTP1, RASSF1A, MASPIN, STAT1, and CASP8.

    • Zinc helps stabilize these functions and mitigate oxidative interference.

    Balancing reactive metals while supporting zinc-dependent structure may help preserve proper epigenetic modulation and cellular equilibrium.

    Zinc’s Role and the Smart Formulation of Telomir-1

    Telomir-1 is formulated with zinc to create Telomir-Zn, a complex engineered to achieve a controlled exchange of metals inside cells-removing excess reactive ions while contributing beneficial zinc. This precision metal-exchange design aims to restore equilibrium rather than broadly deplete metals.

    1. Sequestration: Telomir-1 binds and neutralizes surplus iron and copper, reducing oxidative reactions and metal-ion dependent functions.

    2. Replacement: The compound introduces bioavailable zinc, a vital cofactor for enzymes involved in antioxidant defense and DNA stability.

    Through this dual mechanism, Telomir-1 is believed to function as a dynamic intracellular modulator-helping sustain redox and enzymatic balance that support healthy gene regulation and mitochondrial performance.

    Comparison With Current Chelation Therapies

    Deferoxamine (DFO) (Desferal®) is an FDA-approved iron chelator used clinically for transfusional and acute iron overload. DFO primarily acts in the bloodstream and extracellular space, showing limited penetration into living cells. Chronic or high-dose use can be associated with side effects, including neurological, ocular, or auditory changes and growth suppression in pediatric settings.

    In contrast, the current studies confirm that Telomir-1 demonstrated robust intracellular metal modulation at low micromolar concentrations in vitro. Further studies will continue evaluating its ability to influence metal-ion balance, oxidative chemistry, and epigenetic enzyme activity in pre-clinical models.

    Executive Commentary

    Erez Aminov, Chief Executive Officer of Telomir Pharmaceuticals, stated:

    “The same metals that support growth and development early in life can, when unregulated, contribute to the very processes that drive aging and cellular decline. Our goal with Telomir-1 is to help restore that delicate balance within cells – addressing one of the fundamental factors that link metal homeostasis, oxidative stress, and biological aging. The live-cell imaging results illustrate this concept beautifully – as they say, a picture is worth a thousand words.

    Dr. Itzchak Angel, Chief Scientific Advisor, added:

    “Iron-dependent histone demethylases sit at the intersection of redox biology and gene regulation. Telomir-1’s ability to inhibit several members of this family and to restore balance to intracellular metals provides a mechanistic framework for the methylation patterns we have previously observed. It connects metal homeostasis directly to genomic stability. The direct observation and measurements of the rapid and robust reduction of intracellular iron by Telomir-1 supports and reinforces our understanding of its mechanisms of actions”

    About Telomir Pharmaceuticals

    Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical biotechnology company developing small-molecule therapeutics that target the root epigenetic mechanisms underlying cancer, aging, and degenerative disease. The Company’s lead candidate, Telomir-1, has demonstrated activity in pre-clinical studies involving modulation of DNA and histone methylation, restoration of redox balance, and normalization of cellular function.
    For more information, please visit www.telomirpharma.com.

    Cautionary Note Regarding Forward-Looking Statements

    This press release, statements of Telomir’s management or advisors related thereto, and the statements contained in the news story linked in this release contain “forward-looking statements,” which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications, and the safety of Telomir-1.

    Any forward-looking statements in this press release are based on Telomir’s current expectations, estimates and projections only as of the date of this release. These and other risks concerning Telomir’s programs and operations are described in additional detail in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which are on file with the SEC and available at www.sec.gov. Telomir explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

    Contact Information

    Helga Moya
    info@telomirpharma.com
    (786) 396-6723

    SOURCE: Telomir Pharmaceuticals, Inc

    View the original press release on ACCESS Newswire

  • Equum Medical Partners with Dr. Stephanie Lahr’s Vital Thread Advisory to Scale Virtual Clinical Staffing

    Equum Medical Partners with Dr. Stephanie Lahr’s Vital Thread Advisory to Scale Virtual Clinical Staffing

    Collaboration unites Equum’s 24/7 enterprise telehealth operations with Dr. Lahr’s clinical informatics expertise to help hospitals build always‑on hybrid care

    NEW YORK, NY / ACCESS Newswire / November 12, 2025 / Equum Medical, a leader in integrated acute‑care telehealth and virtual clinical staffing, today announced a strategic partnership with Vital Thread Advisory, the strategic insights firm founded by physician‑executive and telehealth veteran Stephanie Lahr, MD, CHCIO. Together, the organizations will design scalable virtual care operating models that extend hospital capacity, address workforce gaps, and measurably improve patient and clinician experience across the inpatient continuum.

    The collaboration will empower health systems through:

    • Enterprise virtual care operating models: co‑designed coverage frameworks across tele‑ICU, hospitalist and specialty consults, virtual nursing, telemetry, and virtual observation.

    • Workforce optimization & change leadership: competency mapping, clinical workflow redesign, and governance to support hybrid teams.

    • Technology‑enabled service design: platform evaluation, interoperability roadmaps, security & risk management, and value realization plans.

    • Operational analytics & ROI: capacity unlock models, quality and experience metrics, and financial impact tracking tied to executive dashboards.

    “Health systems don’t just need more shifts covered, they need a resilient model that makes care continuous and teams more effective,” said Corey Scurlock, MD, MBA, Founder & CEO of Equum Medical and nationally recognized telehealth leader as well as author of over 70 peer-reviewed publications. “By pairing Equum’s always‑on virtual clinical services with Dr. Lahr’s deep expertise in health system operations and health IT, we can help hospitals move faster, from pilot to enterprise scale, while improving outcomes and reducing burnout.”

    Equum Medical partners with more than 200 health systems, hospitals, and post‑acute facilities nationally who have reported measurable impact from its purpose‑built, digitally enabled clinical services including Multi-Specialty, Critical care, Hospitalist, Virtual Nursing, Sitter and Telemetry.

    “We’re entering a new era of hybrid care where staffing, technology, and workflow must be designed in tandem to provide a comprehensive approach to care,” said Dr. Lahr. “Equum’s model doesn’t merely fill gaps, it amplifies clinicians’ reach across sites and settings. Together, we’ll help health systems expand access, optimize resources, and create a better everyday experience for patients and providers.”

    The partners are engaging with select health systems now and will share early results at upcoming industry meetings including American Telemedicine Association’s Insights Summit on Nov.16-18 in Orlando. Fla. Dr. Lahr and Equum Chief Nursing Officer Kristen Lawton MSN, RN will serve on keynote panels and also present a case study: “Enterprise Virtual Care: Re-engineering the Inpatient Experience from ED to Discharge.” To connect at the Summit or receive more details on the event contact info@equummedical.com

    Media Contact:

    Karsten Russell-Wood
    Chief Marketing & Experience Officer
    karsten.russell-wood@equummedical.com
    (m): 410-409-7376

    About Equum Medical

    Equum Medical is a nationally recognized leader in telehealth-enabled clinical services, helping hospitals and health systems enhance care delivery and serve more patients while achieving positive clinical, operational, and financial outcomes. Equum works with providers large and small – urban and rural – with a focus on ensuring medically underserved communities have access to world-class specialist expertise. Founded over a decade ago by physicians committed to improving equity in access to healthcare, Equum offers a flexible, hybrid-care approach and a wide menu of multi-specialty, critical care, virtual nursing, and other services tailored to the needs of critical access and community hospitals. For more information, visit www.equummedical.com.

    About Vital Thread Advisory

    Vital Thread Advisory partners with health tech companies, startups, health systems and investors to align innovation with the realities of care delivery. Founded by physician and health technology leader Dr. Stephanie Lahr, the firm weaves together clinical expertise, informatics insight, commercial experience and executive leadership to guide strategy, adoption, and growth. With a focus on AI, workflow automation, and digital transformation, Vital Thread Advisory helps organizations design and deliver solutions that reduce friction, create value, and improve the experience of care for patients and clinicians. Dr. Lahr previously served as CIO and CMIO at Monument Health, led health‑tech commercialization and adoption as President of Artisight and today also serves as Chief Medical Officer at uPerform, helping advance scalable, in‑workflow clinical education. For more information, visit www.vitalthreadadvisory.com.

    SOURCE: Equum Medical

    View the original press release on ACCESS Newswire

  • New Orleans Personal Injury Law Firms Targeted in High-Growth Initiative by Click Media for Legal Advertising

    New Orleans Personal Injury Law Firms Targeted in High-Growth Initiative by Click Media for Legal Advertising

    Agency launches specialized digital marketing and lead generation services for New Orleans PI attorneys focused on case volume growth and market expansion.

    NEW ORLEANS, LA / ACCESS Newswire / November 12, 2025 / Click Media, a Louisiana-based digital-first agency, today announced a major new initiative specifically targeting Personal Injury (PI) law firms in New Orleans. The agency is dedicating a specialized division to partner with growth-minded PI firms seeking to expand their reach, significantly increase their qualified case volume, and build a dominant, competitive presence in one of the nation’s most challenging legal markets.

    This initiative is a direct response to the unique, high-stakes environment of Personal Injury law in New Orleans. Click Media’s program is custom-built for PI firms ready to deploy a sophisticated, data-driven, and ROI-focused digital strategy.

    “The New Orleans Personal Injury market is a hyper-competitive arena,” said Taylor McLain, at Click Media. “Generic ‘digital advertising for lawyers‘ simply does not work here. Success demands a specialized, aggressive, and sophisticated approach. We are offering a true partnership to a select number of firms, focusing on measurable outcomes-qualified leads, signed cases, and a transparent, provable return on ad spend.”

    Click Media’s program for Personal Injury firms is built on three core pillars designed for maximum impact:

    Aggressive, ROI-Driven Lead Generation: This pillar is focused on immediate, high-intent client acquisition to fuel case volume. It includes precision management of Google Ads (PPC) and Google Local Service Ads (LSAs) for PI, focusing on high-value keywords for car accidents, 18-wheeler accidents, and offshore injuries.

    Dominant & Authoritative Personal Injury SEO: This long-term strategy builds a durable asset to generate organic leads. It involves hyper-local SEO for New Orleans, high-speed mobile-first technical optimization, and authoritative PI content marketing that establishes E-E-A-T (Experience, Expertise, Authoritativeness, Trust) signals.

    The 24/7 High-Conversion Infrastructure: This pillar re-engineers a firm’s website to be its most effective intake specialist. This includes trust-based, empathetic web design, prominent calls-to-action, 24/7 live chat integration, and transparent ROI reporting for all marketing efforts.

    Click Media is now actively scheduling confidential, no-obligation strategy sessions with ambitious New Orleans Personal Injury law firms that are committed to serious growth and market expansion.

    About Click Media Click Media is a premier, Louisiana-based digital-first agency. While headquartered in Covington, the agency maintains a specialized division with deep expertise in the New Orleans Personal Injury legal market. The team combines advanced technical skill with a nuanced understanding of legal marketing ethics to drive real-world, measurable results.

    Interested firms are encouraged to contact the Click Media PI team directly to schedule a confidential consultation or visit [Your Website URL] for more information on this new program.

    Contact Information

    Emily Blocker
    Public Relations
    emily@click.media
    (985) 200-8888

    Taylor McLain
    Public Relations
    taylor@click.media
    (504) 225-2222

    .

    SOURCE: Click Media

    View the original press release on ACCESS Newswire

  • Dispatch Launches DispatchOne, the AI-Powered Platform Redefining Last-Mile Logistics

    Dispatch Launches DispatchOne, the AI-Powered Platform Redefining Last-Mile Logistics

    With DispatchOne, Dispatch evolves from a delivery service into a technology platform enabling intelligent last-mile logistics for enterprise businesses.

    BLOOMINGTON, MN / ACCESS Newswire / November 12, 2025 / Dispatch, the leader in last-mile logistics innovation, today announced the launch of DispatchOne, its flagship AI-powered platform designed to unify delivery operations and empower enterprises with unparalleled control, intelligence, and reliability across the last mile.

    The launch marks a bold repositioning of Dispatch, evolving from a delivery services provider to a technology platform and orchestration engine. With DispatchOne, businesses gain end-to-end visibility and efficiency, backed by a managed national network of verified professional drivers.

    A Unified Platform for Delivery Intelligence

    DispatchOne combines intelligent logistics, reliable fulfillment, transparent insights, and robust integration into a single ecosystem. By integrating owned fleets, carrier providers, and client systems, DispatchOne delivers what enterprises have long needed: one platform to manage every delivery, with national coverage and proven ROI.

    What’s In The Platform:

    • Orchestrate any fleet: Route and assign across owned assets and third-party carriers from a single source.

    • AI-driven precision: Predictive ETAs, dynamic SLAs, exception handling, and cost/service trade-off recommendations.

    • Reliability at scale: National coverage with a vetted driver network and performance safeguards.

    • Built to connect: RobustAPIs and seamless integrations with TMS, ERP, and eCommerce systems deliver instant value across tech stacks.

    Proven Impact for Enterprises

    Enterprises using DispatchOne are already seeing measurable results, achieving a 93.8% customer satisfaction score (CSAT) and saving over 77 million customer miles through optimized delivery efficiency and intelligent routing.

    “DispatchOne represents more than just a platform launch; it’s the moment we redefine what last-mile logistics can be,” said Alexia Smith, VP of Marketing at Dispatch. “Enterprises no longer have to choose between visibility, reliability, or scale. This positions Dispatch as the partner of choice for businesses ready to turn last-mile logistics into a strategic advantage.”

    About Dispatch: Dispatch redefines the future of last-mile logistics. Its flagship platform, DispatchOne, is the AI-powered operating system that unifies owned fleets, carrier providers, and systems into one intelligent ecosystem. With the people-power of verified and vetted professional driver network, Dispatch turns delivery into a strategic advantage for businesses.

    ###

    Contact Information

    Buse Kayar
    busek@accessnewswire.com

    Alexia Smith
    VP of Marketing
    (952) 444-5280

    .

    SOURCE: Dispatch

    Related Images

    View the original press release on ACCESS Newswire

  • ECM Introduces New Motor Drive and Controller Platform to Accelerate Adoption of PCB Stator Motor Technology

    ECM Introduces New Motor Drive and Controller Platform to Accelerate Adoption of PCB Stator Motor Technology

    Purpose-built platform reduces time, cost, and complexity in developing next-generation PCB Stator motor systems.

    NEEDHAM, MASSACHUSETTS / ACCESS Newswire / November 12, 2025 / ECM PCB Stator Tech has unveiled a suite of more than six internally developed motor drives and controllers engineered specifically for PCB Stator applications, a major step in closing the loop between digital motor design and intelligent hardware control.

    The new platform includes a growing set of hardware reference designs optimized for ECM’s patented PCB Stator motors, enabling scalable, cost-effective, and high-performance control across a wide range of use cases, from compact servos and precision haptics to multi-kilowatt HVAC and robotics systems.

    ECM PCB Stator Tech's Controller Reference Designs

    From Digital Model to Functional Motor – Faster Than Ever

    By combining tightly integrated hardware, flexible firmware, and a software layer purpose-built for real-time control, ECM’s new platform dramatically simplifies the path from simulation to fully functional motor systems. This innovation supports faster prototyping, easier system integration, and lower total cost of ownership, making the adoption of ECM’s disruptive motor technology more accessible than ever.

    This launch marks the next milestone in ECM’s ECMpowered ecosystem – where software-defined motors, intelligent control systems, and compact, efficient form factors converge to redefine electric motion design.

    “Our goal is to close the loop between motor design, firmware, and control,” said Dr. Eric Ponce, Director of Research and Development at ECM PCB Stator Tech. “With this platform, our partners can move from digital motor models to intelligent, production-ready control systems in record time and with minimal friction.”

    For a closer look at the engineering behind ECM’s new controller platform, watch Dr. Eric Ponce’s recent PrintStator in Motion talk here.

    Highlights of ECM’s New Drive and Controller Platform

    Hardware: Rapid Prototyping Meets Scalable Performance

    • More than Six flexible hardware reference designs

    • Scalable from sub 100 W to multi-kW applications

    • Reduction of controller and system-level BOM cost

    • Built-in protection (overcurrent, overvoltage, thermal)

    • Interfaces for sensored and sensorless feedback

    • Tightly integrated custom designs leveraging ECM’s unique form factor

    ECM PCB Stator Servo Motor and Tightly Integrated Controller

    Firmware: Precision Meets Adaptability

    • Imports data directly from PrintStator Motor CAD

    • Real-time parameter estimation and adaptive fault detection

    • Supports sensorless and sensored feedback flexibility

    • High-speed FOC control loops (>20 kHz) for smooth, high-precision motion

    • Common firmware platform across power levels and controller topologies

    Software Layer: Real-Time Insights and Control

    • Enables real-time tuning, measurement, and data logging

    • Supports seamless integration into custom applications or third-party systems

    Enabling a Full-Stack Motor Ecosystem

    This new platform builds on ECM’s mission to provide a full-stack solution for electric motor innovation – from software-defined motor design with PrintStator, to high-efficiency axial flux motors, and now, to intelligent motor control systems. By aligning motor geometry, materials, control algorithms, and interface design, ECM empowers engineers and OEMs to rethink what’s possible in motion systems – and to do it faster.

    ECM PCB Stator Techs Evaluation Motor Range with Integrated Controllers

    ECM PCB Stator Evaluation Motors feature tightly integrated control solutions

    To be ECMpowered means that motors are not simply built, but engineered from the ground up through software intelligence and PCB Stator design to deliver unmatched performance, speed-to-market, and total system value.

    The ECMpowered badge is a mark of advanced electric motor innovation, signalling that partners and products are driving the future of electrification with next-generation performance, efficiency, and design.

    The ECMpowered badge is a mark of advanced electric motor innovation, signalling that partners and products are driving the future of electrification with next-generation performance, efficiency, and design.

    About ECM PCB Stator Tech

    ECM PCB Stator Tech delivers the only full-stack platform for electric motor innovation. It empowers partners to design, prototype, and optimize next-generation PCB Stator motors with precision and speed.

    With PrintStator Motor CAD and patented axial flux hardware, ECM enables the development of compact, efficient, and quiet motors that:

    • Use up to 80% less raw material

    • Weigh up to 70% less than traditional motors

    • Achieve efficiencies in excess of 90 percent

    • Eliminate cogging with near-zero EMI and acoustic signature

    • Enable vertical integration and supply chain control

    Learn more at www.pcbstator.com or watch: How Does a PCB Stator Work? and A New Way to Build Motors Without Winding Lines

    Contact Information

    Sam Jones
    Director of Marketing and Communications
    sjones@pcbstator.com
    www.pcbstator.com

    SOURCE: ECM PCB Stator Tech

    View the original press release on ACCESS Newswire

  • Vero and Soda Capital Partner to Drive Innovation in Floorplan Finance

    Vero and Soda Capital Partner to Drive Innovation in Floorplan Finance

    Vero expands internationally with its first Australian client, bringing next-generation systems to support the expansion of Soda Capital’s wholesale financing platform.

    NEW YORK, NY AND BRISBANE, AUSTRALIA / ACCESS Newswire / November 12, 2025 / Vero, a leading provider of technology systems for the asset finance industry, is excited to announce its strategic partnership with Soda Capital, Australia and New Zealand’s fastest-growing non-bank lender specializing in floorplan and distribution finance. This marks Vero’s first international expansion, as the company continues to pursue opportunities across EMEA and Asia-Pacific to transform asset finance through automation and technology.

    The system went live at the beginning of the month after a comprehensive migration and delivery process supported by both teams.

    Driving Smarter, More Efficient Floorplan Finance

    Soda Capital has built a strong reputation for providing fast, flexible, and transparent financing solutions for manufacturers, distributors, and dealer networks. As it scales, the company is investing in best-in-class technology to optimize its lending operations. By integrating Vero’s innovative platform, Soda Capital will:

    • Automate key workflows in loan origination, servicing, and portfolio management.

    • Enhance risk monitoring with real-time data insights and asset-level tracking.

    • Accelerate decision-making to streamline dealer funding and improve operational efficiency.

    Empowering Growth Through Embedded Finance

    Floorplan financing is evolving rapidly, requiring data-driven decision-making and seamless integration into the broader ecosystem of manufacturers, suppliers, and dealers. Through this partnership, Vero’s end-to-end lending platform will enable Soda Capital to:

    • Provide more self-service tools for their dealer clients, ensuring real-time visibility into asset performance.

    • Optimize credit risk management, proactively identifying potential exposures and reducing inefficiencies.

    • Introduce more dynamic program structures, ensuring they can meet the ever-evolving needs of their vendor and dealer partners.

    A Shared Vision for the Future of Asset Finance

    Both Vero and Soda Capital are technology-first, agile, and forward-thinking organizations that are reshaping the landscape of wholesale financing. With this partnership, Vero will continue to serve as an extension of Soda Capital’s IT team, ensuring continuous innovation, automation, and operational enhancements as its platform scales.

    “Expanding globally has always been part of our vision, and Soda Capital represents the perfect partner for us to enter APAC market. Their commitment to leveraging technology as a differentiator aligns seamlessly with Vero’s mission to modernize floorplan lending, and we’re thrilled to support their next phase of growth.”
    John Mizzi, CEO, Vero

    “Our business is built on speed, transparency, and technology, and Vero’s platform allows us to take that to the next level. With Vero’s expertise in purpose-built solutions for our industry, with a focus on automation and the user experience, we’re confident that we can scale more efficiently while continuing to provide best-in-class financing solutions to our partners and clients.”
    Jordan Edwards, CEO, Soda Capital

    About Vero

    Vero provides an end-to-end SaaS and servicing platform designed to streamline wholesale, supply chain, rental and fleet financing. The modular platform supports every function across a lenders organization with process automation, analytics, and workflow management systems. Vero enables lenders to grow efficiently, reduce manual work, and enhance borrower experiences.

    For more information, visit www.vero-technologies.com.

    About Soda Capital

    Soda Capital is a non-bank lender specializing in floorplan and distribution finance for manufacturers, distributors, and dealer networks. By offering fast, flexible, and innovative financing solutions, Soda Capital empowers businesses to scale efficiently and access the capital they need to succeed.

    For more information, visit www.sodacapital.com.

    Contact: Jason Bartz, info@vero-technologies.com, 404-383-7048

    SOURCE: Vero Finance Technologies

    View the original press release on ACCESS Newswire

  • Euroky Vitality Drink(R) Expands Its Commitment to Wellness and Purpose With Sponsorship of Couture for the Cure Gala

    Euroky Vitality Drink(R) Expands Its Commitment to Wellness and Purpose With Sponsorship of Couture for the Cure Gala

    MIAMI, FL / ACCESS Newswire / November 12, 2025 / Euroky Vitality Drink®, the world’s first multi-functional vitality beverage, proudly sponsored Couture for the Cure, a pink gala fashion event hosted by Posh & Purpose on October 25, 2025, at Bacará Miami Beach. This uplifting evening brought together fashion, art, and community to raise awareness and support during Breast Cancer Awareness Month, in partnership with the nonprofit 305 Pink Pack, which provides direct support to individuals undergoing cancer treatment.

    Euroky Vitality Drink
    Euroky Vitality Drink

    This sponsorship reflects Euroky’s core belief that wellness extends beyond the physical. True vitality comes from living with intention, connection, and care for others. Couture for the Cure embodies this spirit by transforming a fashion-forward celebration into a powerful platform for hope, advocacy, and impact.

    Science-Backed Skin Health: Skin Wrinkling, Collagen and Euroky Vitality Drink®

    Collagen is the most abundant protein in the body, providing structure and support to the skin, hair, nails, joints, and connective tissues. As we age, natural collagen production declines, leading to wrinkles and sagging skin. In fact, starting in our 30s, collagen levels decline at a rate of about 1% per year, leading to visible signs of aging. This has led to the popularity of collagen supplements to replenish lost collagen and maintain youthful skin. Oral collagen supplementation, previously thought to “possibly” have beneficial effects on reducing the appearance of wrinkles is now scientifically proven, in level I high-quality studies, to “definitively” reduce wrinkles. (Critical measurements evaluating biological parameters and actual skin measurements, including the valley to the peak of the wrinkle, were evaluated and these studies have shown that taking at least 3 grams of oral collagen a day for 90 days led to an actual significant decrease in skin wrinkles).

    The three main types of natural oral collagen are either bovine, porcine, or marine derived. Marine collagen is 1.5 times better absorbed in our stomach than bovine or porcine. In addition, it is primarily composed of Type I collagen which is the main type found in our skin.

    We have carefully formulated Euroky Vitality Drink® with 5 grams of an exclusive and premium, Peptan® Marine Collagen sourced from France, under the strictest European Union quality and sustainability standards, and have paired it with high dose Vitamin C to optimize its beneficial effects such as wrinkle reduction.

    Beyond wrinkle reduction, Euroky™ also promotes immunity, brain health, and natural sustained energy, making it a daily companion for those living active and vibrant lifestyles.

    Christopher J. Salgado, MD
    Plastic & Reconstructive Surgery

    Availability

    Euroky Vitality Drink® is available on Amazon and at www.euroky.com.

    For more information, visit www.euroky.com and follow the brand @eurokyvitalitydrink on Instagram for event highlights, wellness education, and exclusive updates.

    Media Inquiries

    For further information, please contact us at info@euroky.com or message us @eurokyvitalitydrink on Instagram

    Contact Information

    Camila Quiñones
    Digital Marketing
    camila@euroky.com
    9542255176

    .

    SOURCE: Euroky Vitality Drink

    View the original press release on ACCESS Newswire

  • Atlas Salt Signs Strategic MOU with Hatch as Lead Engineering and IPD Partner for the Great Atlantic Salt Project

    Atlas Salt Signs Strategic MOU with Hatch as Lead Engineering and IPD Partner for the Great Atlantic Salt Project

    ST. GEORGE’S, NEWFOUNDLAND AND LABRADOR / ACCESS Newswire / November 12, 2025 / Atlas Salt Inc. (“Atlas Salt” or the “Company”) (TSXV:SALT)(OTCQB:REMRF) announces that it has signed a comprehensive non-binding Memorandum of Understanding (“MOU”) with Hatch Ltd. (“Hatch”) establishing Hatch as the Lead Engineering Partner and Integrated Project Delivery (“IPD”) Partner for the Great Atlantic Salt Project (the “Project”).

    Hatch brings over seven decades of global experience designing and delivering some of the world’s largest underground soft-rock mines and has a strong presence in Newfoundland and Labrador. Their mandate within the Project is to integrate all engineering disciplines under an IPD framework, aligning safety, design efficiency, and execution certainty with Atlas Salt’s development strategy.

    Key Elements of the Partnership

    • Safety and Sustainability Leadership: Hatch’s “No Harm” approach to project delivery emphasizes safety-in-design and environmental stewardship, ensuring that health, safety, and environmental performance are prioritized from concept through operations.

    • Integrated Project Delivery: As a full IPD partner, Hatch will collaborate closely with Atlas Salt and other IPD firms to deliver coordinated engineering, risk management, and project controls, reducing execution risks and driving efficient decision-making.

    • Digital Engineering and Project Tools: Hatch will apply advanced digital design systems and information management platforms to streamline engineering, procurement, and construction sequencing, ensuring efficiency and readiness for operations.

    • Local Presence: With a long-standing office in St. John’s, Newfoundland, Hatch is well-positioned to provide on-the-ground support and collaborate directly with Atlas Salt throughout the design and execution phases.

    • Proven Soft-Rock Mining Expertise: Hatch has successfully led engineering and delivery on major underground mining projects across Canada, including potash, nickel, and salt operations. Their deep bench of subject-matter experts in mine, port, and infrastructure design positions the Great Atlantic Salt Project for success.

    Management Commentary
    Nolan Peterson, CEO of Atlas Salt, stated:

    “Hatch’s addition to our Integrated Project Delivery team is a pivotal milestone for the Great Atlantic Salt Project. Their proven track record in large-scale soft-rock mining, combined with their strong presence in Newfoundland and Labrador and commitment to safety and sustainability, provides Atlas Salt with the confidence that the Project will be engineered to the highest global standards.”

    Mike Watters, Global Lead, Mine Infrastructure of Hatch, stated:

    “We are honoured to partner with Atlas Salt on this important project for Newfoundland and Labrador. By applying our integrated project delivery model, digital engineering tools, and commitment to community engagement, Hatch will help ensure the Great Atlantic Salt Project is delivered safely, efficiently, and sustainably.”

    For further information and ongoing updates, please visit https://atlassalt.com.

    The scientific and technical information contained in this news release has been approved by Andrew Smith, P.Eng., ICD.D, Project Director and General Manager, who is a “Qualified Person” for the purposes of NI 43-101.

     

    About Hatch
    Hatch is a global engineering, project delivery, and professional services firm. Whatever our clients envision, our teams can design and build. With over seven decades of business and technical experience in the mining, energy, and infrastructure sectors, we know your business and understand that your challenges are changing rapidly. We respond quickly with solutions that are smarter, more efficient and innovative. We draw upon our 10,000 staff with experience in more than 150 countries to challenge the status quo and create positive change for our clients, our employees, and the communities we serve.

    Find out more on www.hatch.com/About-Us

    About Atlas Salt
    Atlas Salt is developing Canada’s next salt mine and is committed to responsible and sustainable mining practices. With a focus on innovation and efficiency, the company is poised to make significant contributions to the North American salt market while upholding its values of environmental stewardship and community engagement.

    For information, please contact:

    Jeff Kilborn, CFO & VP Corporate Development
    investors@atlassalt.com
    (709) 275-2099

    We seek safe harbour.

    Cautionary Statement
    Neither the TSX Venture Exchange nor its Regulation Services Provider, (as the term is defined in the Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release includes certain “forward-looking information” and “forward-looking statements” (collectively “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein, without limitation, statements relating to the future operating or financial performance of the Company, are forward-looking statements. Forward-looking statements are frequently, but not always, identified by words such as “expects”, “anticipates”, “believes”, “intends”, “estimates”, “potential”, “possible”, and similar expressions, or statements that events, conditions, or results “will”, “may”, “could”, or “should” occur or be achieved. Forward-looking statements in this press release relate to, among other things: obtaining financing, completion, delivery and timing of project components and requirements, and analysis and assumptions related thereto. Actual future results may differ materially. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the respective parties, are inherently subject to significant business, technical, economic, and competitive uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: the timing, completion and delivery of required permits, supply arrangements and financing. Readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these times. Except as required by law, the Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

    SOURCE: Atlas Salt Inc.

    View the original press release on ACCESS Newswire